SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study
Clinical trial NCT05612269 · UNKNOWN
Trial details
- NCT number
- NCT05612269
- Sponsor
- Ministry of Health, Saudi Arabia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-01
- Primary completion
- 2022-10-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.